Literature DB >> 30064659

The Tumor Microenvironment Takes Center Stage in Ovarian Cancer Metastasis.

Marion Curtis1, Abir Mukherjee1, Ernst Lengyel2.   

Abstract

Historically, cancer has been studied at the genomic level with a focus on malignant cells. However, tumors are comprised of various host cells, which are co-opted by cancer cells to promote tumor growth and metastasis. Using multilevel analysis of human tumor biopsies, recent work identifies a reproducible 22-gene expression signature in the ovarian tumor microenvironment (TME) that correlates with disease progression and survival. These findings suggest that the TME is a promising therapeutic target that could be effective across a wide patient population, regardless of the genetic changes within their tumor cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30064659     DOI: 10.1016/j.trecan.2018.06.002

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  10 in total

Review 1.  Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.

Authors:  Zehong Yang; Hongyan Xu; Xiaojun Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-03-20       Impact factor: 16.806

2.  Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved.

Authors:  Letizia Vallino; Alessandra Ferraresi; Chiara Vidoni; Eleonora Secomandi; Andrea Esposito; Danny N Dhanasekaran; Ciro Isidoro
Journal:  J Tradit Complement Med       Date:  2020-03-04

Review 3.  Interactions in the (Pre)metastatic Niche Support Metastasis Formation.

Authors:  Ginevra Doglioni; Sweta Parik; Sarah-Maria Fendt
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

Review 4.  The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors.

Authors:  Denisa Baci; Annalisa Bosi; Matteo Gallazzi; Manuela Rizzi; Douglas M Noonan; Alessandro Poggi; Antonino Bruno; Lorenzo Mortara
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

5.  Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.

Authors:  Xueping Jiang; Yanping Gao; Nannan Zhang; Cheng Yuan; Yuan Luo; Wenjie Sun; Jianguo Zhang; Jiangbo Ren; Yan Gong; Conghua Xie
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

6.  Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer.

Authors:  Jing Jin; Yi Li; Tobias Achu Muluh; Liangke Zhi; Qijie Zhao
Journal:  Front Genet       Date:  2021-07-27       Impact factor: 4.599

Review 7.  Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets.

Authors:  Ralf-Peter Czekay; Dong-Joo Cheon; Rohan Samarakoon; Stacie M Kutz; Paul J Higgins
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

8.  Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer.

Authors:  Isabel J Dionísio de Sousa; Durval S Marques; Catarina Príncipe; Raquel V Portugal; Sule Canberk; Hugo Prazeres; José M Lopes; Etel R P Gimba; Raquel T Lima; Paula Soares
Journal:  Diagnostics (Basel)       Date:  2020-07-28

9.  A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer.

Authors:  Qi Ding; Shanshan Dong; Ranran Wang; Keqiang Zhang; Hui Wang; Xiao Zhou; Jing Wang; Kee Wong; Ying Long; Shuai Zhu; Weigang Wang; Huayi Ren; Yong Zeng
Journal:  Aging (Albany NY)       Date:  2020-03-24       Impact factor: 5.682

Review 10.  Polymeric Hydrogels for In Vitro 3D Ovarian Cancer Modeling.

Authors:  Simona Braccini; Chiara Tacchini; Federica Chiellini; Dario Puppi
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.